Shelter Pharma Ltd — Important, 16-01-2026: Company Update

Shelter Pharma's Registrar and Share Transfer Agent confirmed the company is exempt from certain dematerialization reporting requirements (Regulation 74(5)). This is because all of the company's shares are held in dematerialized form. Additionally, no shareholder requests for converting physical shares to demat or vice versa were received during the quarter ending 31st December 2025, ensuring smooth compliance regarding its share registry.